| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | HERON THERAPEUTICS INC | 4,408,987 | 61,329,000 | 29.74% | ||
| 2 | PDL BIOPHARMA INC | 25,974,000 | 40,197,000 | 19.49% | PRN | |
| 3 | SALIX PHARMACEUTICALS INC | 300,000 | 31,083,000 | 15.07% | ||
| 4 | OPKO Health Inc. | 14,000,000 | 19,040,000 | 9.23% | PRN | |
| 5 | Horizon Pharma Inc | 1,000,000 | 15,120,000 | 7.33% | ||
| 6 | BIOMARIN | 182,300 | 12,435,000 | 6.03% | ||
| 7 | ENDOCYTE INC | 465,763 | 11,090,000 | 5.38% | ||
| 8 | MIRATI THERAPEUTICS INC COM | 435,843 | 8,312,000 | 4.03% | ||
| 9 | MANNKIND CORPORATION | 1,800,000 | 7,236,000 | 3.51% | ||
| 10 | Dendreon Corp | 55,548 | 166,000 | 0.08% | ||
| 11 | LA JOLLA PHARMACEUTICAL CO | 11,219 | 121,000 | 0.06% | ||
| 12 | RXI PHARMACEUTICALS CORP NEW | 18,245 | 78,000 | 0.04% | ||
| 13 | AMBIT BIOSCIENCES CORP | 46 | 0 | 0.00% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001214659-14-003661, filed 2014.05.15).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
